Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART Trial of Antipsychotics in First-Episode Schizophrenia
NCT03510325Phase 3Completed
- Sponsor
- Shanghai Mental Health Center
- Start
- Feb 2019
- Primary completion
- Sep 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of clozapine in schizophrenia, schizophreniform disorder, schizoaffective disorder, sponsored by Shanghai Mental Health Center. Started Feb 2019; status: completed.
02
Drugs
clozapine
03
Conditions
schizophreniaschizophreniform disorderschizoaffective disorder
Beyond the preview
Go deeper on NCT03510325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03510325.